Provide copies of all documents, including memos, briefing notes, reports, e-mails, texts or
Instant messages, decision notes, WhatsApp messages, slack messages, correspondence,
meeting notes, etc., showing all discussion/negotiation over which drugs to make part the
Common list of drugs as part of the National Strategy for Drugs for Rare Diseases
(https://www.canada.ca/en/health-canada/corporate/transparency/health-agreements/sharedhealth-
priorities/drugs-for-rare-diseases-bilateral-agreements/common-list-drugs.html).
Timeframe: January 1, 2022 - March 26, 2025.
